One of New Zealand’s largest hospitals has chosen to purchase their first Bioquell BQ-50 suite to help them combat COVID-19. The hospital is well versed in performing airborne disinfection with alternative technologies but has selected Bioquell to improve their decontamination capabilities. The Bioquell BQ-50 has been chosen due to its emphasis on operator and patient […]Read More
A hospital in Kent has recently purchased 3 Bioquell PODs after identifying that their current set-up was not adequate for viral or bacterial infection outbreaks. The plan is to transform part of their High Dependency Unit into segregated areas using the Bioquell PODs. The Bioquell POD is an ideal solution for converting open wards to […]Read More
Bioquell hydrogen peroxide vapor technology has been used in Duke’s latest study. See a link to the study and other news here: https://www.dukechronicle.com/article/2020/03/duke-health-researchers-decontaminate-n95-face-masks-reuseRead More
Bioquell, an Ecolab Solution, is in the news as the FDA grants an Emergency Use Authorization (EUA) for Battelle and its CCDS Critical Care Decontamination System. See the full story here about the efforts taking place with this a Columbus-based non-profit. Read more on USA Today.Read More
An article recently featured in Building Better Healthcare discusses how one hospital is using Bioquell BQ-50 systems to help to stop the spread of norovirus, MRSA, and other drug-resistant micro-organisms. It reviews Bioquell’s technology and how it is ideal for hospital settings. Importantly, the article states that Bioquell technology “can get into all of the […]Read More
Join Bioquell at booth 1804 at BioProcess International during Biotech Week Boston which will bring together more than 2,000 scientists, engineers and executives working across the entire spectrum of biopharmaceutical development and production.